RecallDepth
Class II Terminated

Ceftazidime Sterile Ophthalmic Solution for Injection Preservative Free 11.25mg / 0.5ml (22.5mg/ml) 0.5ml per syringe. KEEP FROZEN UNTIL USE AND PROTECT FROM LIGHT SINGLE USE SYRINGE FOR INTRAOCULAR INJECTION Edge Pharma, LLC is an FDA-registered 503B outsourcing facility. This is a compounded (re-packaged) drug. Not for Resale, Hospital/Office use only. Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178

Company
Edge Pharma, Llc
Recall Initiated
March 19, 2020
Posted
January 27, 2021
Recall Number
D-0238-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
48 syringes
Firm Location
Colchester, VT, United States

Reason for Recall

Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot # 02-2020-04@4

More recalls by Edge Pharma, Llc

View all recalls by this company →

Other recent Class II Drug recalls